Regions Financial Corp’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$689K Buy
1,781
+241
+16% +$89.4K ﹤0.01% 564
2026
Q1
$451K Sell
1,540
-586
-28% -$193K ﹤0.01% 637
2025
Q4
$745K Buy
2,126
+100
+5% +$33.8K ﹤0.01% 527
2025
Q3
$655K Sell
2,026
-439
-18% -$137K ﹤0.01% 577
2025
Q2
$959K Sell
2,465
-99
-4% -$39.8K 0.01% 495
2025
Q1
$1.12M Sell
2,564
-305
-11% -$122K 0.01% 465
2024
Q4
$1.06M Sell
2,869
-1,509
-34% -$631K 0.01% 469
2024
Q3
$2.28M Sell
4,378
-116
-3% -$62K 0.02% 353
2024
Q2
$2.44M Sell
4,494
-105
-2% -$55.5K 0.02% 336
2024
Q1
$2.38M Sell
4,599
-678
-13% -$337K 0.02% 345
2023
Q4
$2.49M Sell
5,277
-311
-6% -$144K 0.02% 325
2023
Q3
$2.43M Sell
5,588
-343
-6% -$156K 0.02% 317
2023
Q2
$2.64M Sell
5,931
-749
-11% -$346K 0.02% 313
2023
Q1
$3.07M Sell
6,680
-76
-1% -$36.2K 0.03% 274
2022
Q4
$3.46M Sell
6,756
-315
-4% -$160K 0.03% 252
2022
Q3
$3.21M Sell
7,071
-1,014
-13% -$485K 0.03% 250
2022
Q2
$3.9M Sell
8,085
-523
-6% -$259K 0.04% 232
2022
Q1
$4.23M Sell
8,608
-6
-0.1% -$2.74K 0.03% 245
2021
Q4
$3.99M Buy
8,614
+105
+1% +$44.2K 0.03% 271
2021
Q3
$3.17M Sell
8,509
-192
-2% -$73K 0.03% 290
2021
Q2
$3.32M Buy
8,701
+320
+4% +$122K 0.03% 285
2021
Q1
$3.01M Buy
8,381
+153
+2% +$49.2K 0.03% 284
2020
Q4
$2.64M Sell
8,228
-218
-3% -$66.9K 0.03% 293
2020
Q3
$2.27M Sell
8,446
-602
-7% -$162K 0.02% 290
2020
Q2
$2.38M Buy
9,048
+243
+3% +$64.8K 0.03% 274
2020
Q1
$2M Sell
8,805
-298
-3% -$81.2K 0.03% 269
2019
Q4
$2.75M Sell
9,103
-432
-5% -$119K 0.03% 261
2019
Q3
$2.29M Sell
9,535
-502
-5% -$138K 0.03% 271
2019
Q2
$2.83M Buy
10,037
+1,260
+14% +$344K 0.03% 255
2019
Q1
$2.52M Sell
8,777
-337
-4% -$97.5K 0.03% 259
2018
Q4
$2.39M Buy
9,114
+472
+5% +$130K 0.03% 247
2018
Q3
$2.37M Sell
8,642
-54
-0.6% -$14K 0.03% 280
2018
Q2
$2.07M Buy
8,696
+642
+8% +$149K 0.02% 302
2018
Q1
$1.77M Sell
8,054
-7,028
-47% -$1.65M 0.02% 331
2017
Q4
$3.39M Sell
15,082
-1,142
-7% -$243K 0.04% 228
2017
Q3
$3.08M Buy
16,224
+3,582
+28% +$682K 0.04% 232
2017
Q2
$2.38M Sell
12,642
-1,871
-13% -$336K 0.03% 267
2017
Q1
$2.4M Buy
14,513
+514
+4% +$81.8K 0.03% 252
2016
Q4
$2.01M Sell
13,999
-777
-5% -$104K 0.02% 292
2016
Q3
$1.85M Buy
14,776
+619
+4% +$79.9K 0.02% 306
2016
Q2
$1.86M Buy
14,157
+1,197
+9% +$164K 0.02% 302
2016
Q1
$1.8M Buy
12,960
+7,438
+135% +$994K 0.02% 319
2015
Q4
$770K Buy
5,522
+664
+14% +$91.5K 0.01% 544
2015
Q3
$681K Buy
4,858
+781
+19% +$117K 0.01% 577
2015
Q2
$669K Buy
4,077
+980
+32% +$157K 0.01% 582
2015
Q1
$478K Buy
3,097
+137
+5% +$19.5K 0.01% 651
2014
Q4
$372K Sell
2,960
-8,441
-74% -$1.04M ﹤0.01% 709
2014
Q3
$1.36M Sell
11,401
-2,921
-20% -$335K 0.02% 490
2014
Q2
$1.54M Sell
14,322
-11,131
-44% -$1.15M 0.02% 464
2014
Q1
$2.53M Sell
25,453
-16,498
-39% -$1.49M 0.03% 291
2013
Q4
$3.88M Sell
41,951
-3,320
-7% -$295K 0.05% 222
2013
Q3
$3.79M Sell
45,271
-2,114
-4% -$181K 0.05% 212
2013
Q2
$3.88M Buy
+47,385
New +$3.55M 0.05% 198

Other funds holding ELV

Regions Financial Corp's ELV Position: Q2 2026 in Review

Regions Financial Corp increased its Elevance Health (ELV) stake by 16% in Q2 2026, buying an estimated $89.4K and bringing the position to 1,781 shares worth $689K. The position accounts for ﹤0.01% of the portfolio, ranked #564.

Regions Financial Corp first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.23M in Q1 2022. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Regions Financial Corp held 1,781 shares of Elevance Health worth $689K as of Q2 2026.
  • Regions Financial Corp bought 241 Elevance Health shares in Q2 2026, an estimated $89.4K.
  • Elevance Health made up ﹤0.01% of Regions Financial Corp's portfolio in Q2 2026, its #564 holding.
  • Regions Financial Corp first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
  • Regions Financial Corp's Elevance Health position peaked at $4.23M in Q1 2022.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Regions Financial Corp's 13F filing for Q2 2026, filed 10 Aug 2026.